CPNET
MCID: CNT044
MIFTS: 28

Central Nervous System Primitive Neuroectodermal Neoplasm (CPNET)

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Central Nervous System Primitive Neuroectodermal Neoplasm

MalaCards integrated aliases for Central Nervous System Primitive Neuroectodermal Neoplasm:

Name: Central Nervous System Primitive Neuroectodermal Neoplasm 12 15
Cpnet 71

Classifications:



External Ids:

Disease Ontology 12 DOID:0060103
UMLS 71 C3887678

Summaries for Central Nervous System Primitive Neuroectodermal Neoplasm

Disease Ontology : 12 A central nervous system cancer of children and young adults that develops from neural crest cells located in cerebrum, has material basis in abnormally proliferating cells derives from neuroectoderm.

MalaCards based summary : Central Nervous System Primitive Neuroectodermal Neoplasm, also known as cpnet, is related to childhood central nervous system primitive neuroectodermal neoplasm and adult central nervous system primitive neuroectodermal neoplasm. An important gene associated with Central Nervous System Primitive Neuroectodermal Neoplasm is DICER1 (Dicer 1, Ribonuclease III), and among its related pathways/superpathways are Neuroscience and Embryonic and Induced Pluripotent Stem Cells and Lineage-specific Markers. Affiliated tissues include cerebrum, brain and ovary, and related phenotypes are Increased proliferation and muscle

Related Diseases for Central Nervous System Primitive Neuroectodermal Neoplasm

Diseases in the Central Nervous System Primitive Neuroectodermal Neoplasm family:

Adult Central Nervous System Primitive Neuroectodermal Neoplasm

Diseases related to Central Nervous System Primitive Neuroectodermal Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 235, show less)
# Related Disease Score Top Affiliating Genes
1 childhood central nervous system primitive neuroectodermal neoplasm 34.6 PCDHGA3 OR4C12
2 adult central nervous system primitive neuroectodermal neoplasm 12.8
3 myoblastoma 10.5 SYP ENO2
4 malignant melanocytic neoplasm of the peripheral nerve sheath 10.5 SYP ENO2
5 anal neuroendocrine tumor 10.5 SYP ENO2
6 breast neuroendocrine neoplasm 10.5 SYP ENO2
7 sinonasal undifferentiated carcinoma 10.5 SYP ENO2
8 papillary tumor of the pineal region 10.5 SYP ENO2
9 small cell carcinoma of the bladder 10.5 SYP ENO2
10 auditory system benign neoplasm 10.5 SYP ENO2
11 appendix carcinoid tumor 10.5 SYP ENO2
12 auditory system cancer 10.5 SYP ENO2
13 cauda equina neoplasm 10.5 SYP ENO2
14 duodenal benign neoplasm 10.5 SYP ENO2
15 nodular prostate 10.5 SYP ENO2
16 myocardium cancer 10.5 SYP CD99
17 ampulla of vater neoplasm 10.5 SYP ENO2
18 urinary bladder small cell neuroendocrine carcinoma 10.5 SYP ENO2
19 ureter small cell carcinoma 10.5 SYP ENO2
20 cerebellar liponeurocytoma 10.5 SYP ENO2
21 middle ear adenoma 10.5 SYP ENO2
22 extraventricular neurocytoma 10.5 SYP GFAP
23 large cell carcinoma with rhabdoid phenotype 10.5 SMARCB1 ENO2
24 jejunal neoplasm 10.5 SYP ENO2
25 carotid body cancer 10.5 SYP ENO2
26 gallbladder small cell carcinoma 10.5 SYP ENO2
27 gastric small cell carcinoma 10.5 SYP ENO2
28 sensory organ benign neoplasm 10.5 SYP ENO2
29 lung combined type small cell carcinoma 10.5 SYP GFAP
30 pineal parenchymal tumor of intermediate differentiation 10.5 SYP ENO2
31 ovarian large-cell neuroendocrine carcinoma 10.5 SYP ENO2
32 gastric hemangioma 10.5 SYP ENO2
33 lung oat cell carcinoma 10.5 SYP ENO2
34 cutaneous ganglioneuroma 10.5 SYP ENO2
35 cervix small cell carcinoma 10.5 SYP ENO2
36 carcinoid tumors, intestinal 10.5 SYP ENO2
37 intracranial cysts 10.5 GFAP ENO2
38 primitive neuroectodermal tumor of the cervix uteri 10.5 GFAP ENO2
39 anaplastic ganglioglioma 10.4 NES GFAP
40 orbital cancer 10.4 SYP ENO2
41 central nervous system immature teratoma 10.4 NES GFAP
42 kidney rhabdoid cancer 10.4 SMARCB1 ENO2
43 tanycytic ependymoma 10.4 SYP GFAP
44 carcinoid syndrome 10.4 SYP ENO2
45 angiocentric glioma 10.4 SYP GFAP
46 chiari malformation 10.4 SYP GFAP
47 endometrial small cell carcinoma 10.4 SYP ENO2
48 gliofibroma 10.4 GFAP CD99
49 colon neuroendocrine neoplasm 10.4 SYP ENO2
50 ewing sarcoma of bone 10.4 ENO2 CD99
51 nasal cavity olfactory neuroblastoma 10.4 SYP ENO2
52 cerebral primitive neuroectodermal tumor 10.4 SYP MYCN
53 central nervous system mesenchymal non-meningothelial tumor 10.4 ENO2 CD99
54 pulmonary neuroendocrine tumor 10.4 SYP ENO2
55 cellular ependymoma 10.4 SYP CD99
56 bladder lateral wall cancer 10.4 SYP ENO2
57 binswanger's disease 10.4 SYP GFAP
58 anaplastic ependymoma 10.4 SYP GFAP
59 small intestine benign neoplasm 10.4 SYP ENO2
60 ectomesenchymoma 10.4 ENO2 CD99
61 nodular ganglioneuroblastoma 10.4 MYCN ENO2
62 chordoid meningioma 10.4 SYP GFAP
63 endobronchial lipoma 10.4 SYP ENO2
64 mediastinal cancer 10.4 SYP ENO2
65 uterus leiomyosarcoma 10.4 SYP ENO2
66 pineal region teratoma 10.4 SYP SMARCB1 ENO2
67 optic nerve astrocytoma 10.4 SYP SMARCB1 ENO2
68 small cell osteogenic sarcoma 10.4 ENO2 CD99
69 sertoli-leydig cell tumor 10.4 SYP ENO2 DICER1
70 central epithelioid sarcoma 10.4 SYP SMARCB1
71 horseshoe kidney 10.4 SYP ENO2
72 extraosseous chondrosarcoma 10.4 SYP SMARCB1 ENO2
73 ovarian small cell carcinoma 10.4 SYP SMARCB1 ENO2
74 vulvar proximal-type epithelioid sarcoma 10.3 SYP SMARCB1
75 juvenile type testicular granulosa cell tumor 10.3 SMARCB1 DICER1 CD99
76 testicular granulosa cell tumor 10.3 SMARCB1 DICER1 CD99
77 traumatic brain injury 10.3 GFAP ENO2
78 mesenchymal chondrosarcoma 10.3 SYP SMARCB1 ENO2
79 intracranial primitive neuroectodermal tumor 10.3 SYP ENO2 CD99
80 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.3 SYP ENO2 CD99
81 extraskeletal ewing sarcoma 10.3 SYP ENO2 CD99
82 cerebral neuroblastoma 10.3 SYP GFAP ENO2
83 extraosseous ewing sarcoma 10.3 SYP ENO2 CD99
84 papillary ependymoma 10.3 SYP GFAP ENO2
85 pineocytoma 10.3 SYP GFAP ENO2
86 neuroma 10.3 SMARCB1 GFAP ENO2
87 clear cell meningioma 10.3 SYP SMARCB1 GFAP
88 myxopapillary ependymoma 10.3 SYP SMARCB1 GFAP
89 endobronchial leiomyoma 10.3 SYP GFAP ENO2
90 clear cell ependymoma 10.3 SYP GFAP ENO2
91 gangliocytoma 10.3 SYP GFAP ENO2
92 melanotic neuroectodermal tumor 10.3 SYP GFAP ENO2
93 hemangiopericytoma, malignant 10.3 SYP ENO2 CD99
94 obstructive hydrocephalus 10.3 SYP GFAP ENO2
95 sarcomatoid transitional cell carcinoma 10.3 TP53 SYP
96 granular cell tumor 10.3 SYP GFAP ENO2
97 dysembryoplastic neuroepithelial tumor 10.3 SYP NES GFAP
98 cystic basal cell carcinoma 10.3 SYP ENO2
99 melanotic medulloblastoma 10.3 SMARCB1 SHH
100 cervical neuroblastoma 10.3 SYP MYCN ENO2
101 adrenal neuroblastoma 10.3 SYP MYCN ENO2
102 extracranial neuroblastoma 10.3 SYP MYCN ENO2
103 juvenile pilocytic astrocytoma 10.3 SYP NES GFAP
104 optic nerve glioma 10.3 NES GFAP ENO2
105 autonomic nervous system benign neoplasm 10.3 SYP MYCN ENO2
106 peripheral nervous system benign neoplasm 10.3 SYP MYCN ENO2
107 hemangioblastoma 10.3 SYP GFAP ENO2
108 desmoplastic infantile ganglioglioma 10.3 SYP MYCN GFAP
109 subleukemic leukemia 10.3 SYP ENO2
110 retroperitoneal neuroblastoma 10.2 MYCN ENO2 CD99
111 paraganglioma 10.2 SYP GFAP ENO2
112 urethra transitional cell carcinoma 10.2 TP53 GFAP
113 microcystic adenoma 10.2 SYP ENO2
114 glomangiomatosis 10.2 TP53 SYP
115 pulmonary blastoma 10.2 TP53 SYP DICER1
116 wilms tumor predisposition 10.2 TP53 DICER1
117 keratinizing squamous cell carcinoma 10.2 TP53 SMARCB1
118 pulmonary sclerosing hemangioma 10.2 SYP ENO2
119 papillary adenoma 10.2 TP53 SYP
120 laryngeal neuroendocrine tumor 10.2 TP53 SYP SMARCB1
121 bile duct mucinous adenocarcinoma 10.2 TP53 SYP ENO2
122 gemistocytic astrocytoma 10.2 TP53 GFAP
123 rhabdoid meningioma 10.1 SYP SMARCB1 GFAP ENO2
124 rhabdoid tumor predisposition syndrome 1 10.1 TP53 SYP SMARCB1
125 granulosa cell tumor of the ovary 10.1 TP53 SYP ENO2
126 subependymoma 10.1 SYP NES GFAP ENO2
127 basaloid squamous cell carcinoma 10.1 TP53 SYP ENO2
128 glomus tumor 10.1 TP53 SYP ENO2
129 respiratory system benign neoplasm 10.1 TP53 SYP ENO2
130 peritoneal serous adenocarcinoma 10.1 TP53 SYP
131 central neurocytoma 10.1 SYP NES GFAP ENO2
132 mixed cell type cancer 10.1 TP53 SYP ENO2
133 subependymal giant cell astrocytoma 10.1 SYP NES GFAP ENO2
134 benign teratoma 10.1 TP53 SYP ENO2
135 cerebellopontine angle primitive neuroectodermal tumor 10.1 SYP GFAP ENO2 CD99
136 thymic carcinoma 10.1 TP53 SYP ENO2
137 benign ependymoma 10.1 SYP NES GFAP ENO2
138 sclerosing hemangioma 10.1 SYP ENO2
139 adult medulloblastoma 10.1 SHH MYCN
140 olfactory nerve neoplasm 10.1 SYP GFAP ENO2 CD99
141 cranial nerve malignant neoplasm 10.1 SYP GFAP ENO2 CD99
142 medullomyoblastoma 10.1 SYP SHH GFAP
143 lung benign neoplasm 10.1 TP53 SYP ENO2
144 cardiovascular organ benign neoplasm 10.1 TP53 SYP ENO2
145 chordoid glioma 10.1 TP53 SYP GFAP
146 neurilemmoma 10.1 SMARCB1 NES GFAP ENO2
147 conventional fibrosarcoma 10.1 TP53 ENO2
148 corpus callosum lipoma 10.1 SMARCB1 SHH
149 endocrine organ benign neoplasm 10.1 TP53 SYP ENO2
150 sweat gland benign neoplasm 10.1 TP53 SMARCB1 GFAP
151 askin's tumor 10.1 SYP MYCN ENO2 CD99
152 cerebral hemisphere lipoma 10.1 SMARCB1 SHH
153 myoepithelial carcinoma 10.1 TP53 SMARCB1 GFAP
154 mixed glioma 10.1 TP53 NES GFAP
155 adrenal carcinoma 10.1 TP53 SYP ENO2
156 small cell cancer of the lung 10.1 TP53 SYP ENO2
157 embryonal rhabdomyosarcoma 10.1 TP53 MYCN DICER1
158 germ cell cancer 10.0 NES MIR371A LIN28A ENO2
159 brain glioma 10.0 TP53 NES GFAP
160 sarcoma, synovial 10.0 SMARCB1 NES MYCN CD99
161 bone sarcoma 10.0 TP53 ENO2 CD99
162 chordoma 10.0 TP53 SMARCB1 GFAP
163 grade iii astrocytoma 10.0 TP53 NES GFAP
164 olfactory neuroblastoma 9.9 SYP SHH ENO2 CD99
165 pleomorphic xanthoastrocytoma 9.9 TP53 SYP SMARCB1 GFAP
166 cranial nerve neoplasm 9.9 SYP SMARCB1 GFAP ENO2 CD99
167 spinal cord oligodendroglioma 9.9 TP53 SYP GFAP ENO2
168 oligodendroglioma 9.9 TP53 SYP GFAP ENO2
169 chondrosarcoma, extraskeletal myxoid 9.9 SYP SMARCB1 GFAP ENO2 CD99
170 cystic teratoma 9.9 TP53 SYP GFAP ENO2
171 merkel cell carcinoma 9.9 TP53 SYP ENO2 CD99
172 keratocystic odontogenic tumor 9.9 TP53 SHH
173 gliomatosis cerebri 9.9 TP53 SYP NES GFAP
174 nodular medulloblastoma 9.9 SYP SMARCB1 SHH MYCN
175 rhabdoid cancer 9.9 TP53 SMARCB1 SHH
176 frontal lobe neoplasm 9.9 TP53 SYP MYCN ENO2
177 cerebral degeneration 9.9 SYP SHH NES GFAP
178 prostate neuroendocrine neoplasm 9.9 TP53 SYP MYCN ENO2
179 ganglioneuroblastoma 9.9 TP53 SYP MYCN ENO2
180 dermatofibrosarcoma protuberans 9.9 TP53 NES ENO2 CD99
181 malignant teratoma 9.9 SYP MIR371A LIN28A ENO2 CD99
182 small cell carcinoma 9.9 TP53 SYP MYCN ENO2
183 mature teratoma 9.9 TP53 SYP MIR371A ENO2
184 autonomic nervous system neoplasm 9.9 TP53 SYP MYCN ENO2
185 peripheral nervous system neoplasm 9.9 TP53 SYP MYCN ENO2
186 ganglioneuroma 9.9 SYP MYCN GFAP ENO2 CD99
187 germ cell and embryonal cancer 9.9 TP53 NES MIR371A LIN28A
188 neurofibrosarcoma 9.8 TP53 ENO2
189 cerebrovascular benign neoplasm 9.8 TP53 SYP SMARCB1 GFAP ENO2
190 spinal cancer 9.8 TP53 SYP SMARCB1 GFAP ENO2
191 papilloma of choroid plexus 9.8 TP53 SYP SMARCB1 GFAP ENO2
192 gastrointestinal stromal tumor 9.8 TP53 SYP SMARCB1 NES ENO2
193 giant cell glioblastoma 9.7 TP53 SYP SMARCB1 NES GFAP
194 suppression of tumorigenicity 12 9.7 TP53 SYP MYCN ENO2 DICER1
195 gliosarcoma 9.7 TP53 SYP NES GFAP ENO2
196 tuberous sclerosis 9.7 TP53 SYP NES GFAP ENO2
197 pleuropulmonary blastoma 9.7 TP53 SHH MYCN DICER1
198 central nervous system benign neoplasm 9.7 TP53 SYP MYCN GFAP ENO2
199 ewing sarcoma 9.7 TP53 SYP MYCN ENO2 CD99
200 basal cell nevus syndrome 9.7 TP53 SMARCB1 SHH MYCN
201 retinoblastoma 9.7 TP53 SYP SMARCB1 MYCN ENO2
202 li-fraumeni syndrome 9.7 TP53 SMARCB1 SHH MYCN
203 medulloepithelioma 9.6 SYP SMARCB1 NES LIN28A GFAP ENO2
204 cerebellar medulloblastoma 9.6 TP53 SYP SHH GFAP ENO2
205 hydrocephalus 9.5 TP53 SYP SMARCB1 NES GFAP ENO2
206 muscle cancer 9.5 TP53 SYP SMARCB1 MYCN ENO2 CD99
207 astroblastoma 9.5 SYP NES GFAP FOXR2 ENO2
208 infratentorial cancer 9.5 TP53 SMARCB1 SHH NES MYCN
209 neural tube defects 9.5 TP53 SYP SHH GFAP ENO2
210 brain stem glioma 9.4 TP53 SHH NES MYCN GFAP
211 retinal detachment 9.4 TP53 GFAP ENO2
212 basal cell carcinoma 9.4 TP53 SYP SHH MYCN
213 atypical teratoid rhabdoid tumor 9.4 TP53 SYP SMARCB1 SHH LIN28A GFAP
214 meningioma, familial 9.4 TP53 SYP SMARCB1 SHH GFAP ENO2
215 leber plus disease 9.3 TP53 SYP SHH GFAP ENO2 CD99
216 cerebrum cancer 9.3 TP53 SYP SMARCB1 NES MYCN GFAP
217 cerebral ventricle cancer 9.3 TP53 SYP SMARCB1 NES MYCN GFAP
218 ganglioglioma 9.3 TP53 SYP SMARCB1 NES MYCN GFAP
219 cerebellum cancer 9.3 TP53 SYP SHH MYCN GFAP ENO2
220 glioblastoma multiforme 9.2 TP53 SYP SHH NES MYCN GFAP
221 wilms tumor 1 9.2 TP53 SYP SMARCB1 MYCN LIN28A ENO2
222 supratentorial primitive neuroectodermal tumor 9.2 SYP SMARCB1 SHH MYCN MIR520G GFAP
223 pineoblastoma 9.2 SYP PCDHGA3 OR4C12 GFAP FOXR2 DICER1
224 skeletal muscle cancer 9.1 TP53 SYP SMARCB1 SHH MYCN ENO2
225 central nervous system cancer 9.1 TP53 SYP SMARCB1 SHH NES MYCN
226 teratoma 9.0 TP53 SYP SMARCB1 SHH NES GFAP
227 choroid plexus cancer 8.9 TP53 SYP SMARCB1 SHH GFAP FOXR2
228 rhabdomyosarcoma 8.9 TP53 SYP SHH NES MYCN ENO2
229 neuroblastoma 8.9 TP53 SYP SHH NES MYCN GFAP
230 supratentorial cancer 8.9 TP53 SYP SMARCB1 SHH NES MYCN
231 brain cancer 8.9 TP53 SYP SMARCB1 SHH NES MYCN
232 pineal gland cancer 8.8 SYP SMARCB1 PCDHGA3 OR4C12 GFAP FOXR2
233 retinitis pigmentosa 8.8 TP53 SHH NES MYCN LIN28A GFAP
234 medulloblastoma 8.8 TP53 SYP SMARCB1 SHH NES MYCN
235 ependymoblastoma 7.8 SYP SMARCB1 NES MYCN MIR520G MIR518C

Graphical network of the top 20 diseases related to Central Nervous System Primitive Neuroectodermal Neoplasm:



Diseases related to Central Nervous System Primitive Neuroectodermal Neoplasm

Symptoms & Phenotypes for Central Nervous System Primitive Neuroectodermal Neoplasm

GenomeRNAi Phenotypes related to Central Nervous System Primitive Neuroectodermal Neoplasm according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased proliferation GR00094-A 8.62 SMARCB1 TP53

MGI Mouse Phenotypes related to Central Nervous System Primitive Neuroectodermal Neoplasm:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 9.17 DICER1 GFAP LIN28A MYCN SHH SMARCB1

Drugs & Therapeutics for Central Nervous System Primitive Neuroectodermal Neoplasm

Search Clinical Trials , NIH Clinical Center for Central Nervous System Primitive Neuroectodermal Neoplasm

Genetic Tests for Central Nervous System Primitive Neuroectodermal Neoplasm

Anatomical Context for Central Nervous System Primitive Neuroectodermal Neoplasm

The Foundational Model of Anatomy Ontology organs/tissues related to Central Nervous System Primitive Neuroectodermal Neoplasm:

19
Cerebrum

MalaCards organs/tissues related to Central Nervous System Primitive Neuroectodermal Neoplasm:

40
Brain, Ovary, Uterus

Publications for Central Nervous System Primitive Neuroectodermal Neoplasm

Articles related to Central Nervous System Primitive Neuroectodermal Neoplasm:

(showing 27, show less)
# Title Authors PMID Year
1
[Clinical effect of surgery combined with chemotherapy and radiotherapy in children with central primitive neuroectodermal tumor and prognostic analysis]. 61
32571457 2020
2
Intracranial Ewing Sarcoma - A case report. 61
32547821 2020
3
ZBTB16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma. 61
31326195 2019
4
Ewing-Like Sarcoma: A Case of a Primary Cutaneous Primitive Neuroectodermal Tumor With Atypical Immunohistochemistry and Lack of Fusion Oncogene Detection. 61
30067549 2018
5
[Survival and prognostic factors analysis of primitive neuroectodermal tumor]. 61
30139033 2018
6
Cystic pancreatic neuroendocrine tumor. Pancreatic endocrine or neuroendocrine tumor. Endoscopic ultrasonography. 61
29313698 2018
7
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature. 61
29480840 2018
8
Primary intracranial dural-based Ewing sarcoma/peripheral primitive neuroectodermal tumor mimicking a meningioma: A rare tumor with review of literature. 61
28761507 2017
9
Comparison of Primary Spinal Central and Peripheral Primitive Neuroectodermal Tumors in Clinical and Imaging Characteristics and Long-Term Outcome. 61
26748171 2016
10
Cervicomedullary intramedullary peripheral primitive neuroectodermal tumor with intratumoral bleed: Report of one case and review of literature. 61
27217659 2016
11
The imaging findings of infratentorial primitive neuroectodermal tumour: A case report. 61
26493270 2015
12
Novel treatment of a central type, primitive neuroectodermal tumor of the ovary with postoperative pediatric medulloblastoma chemotherapy regimen: A case report and review of the literature. 61
26425724 2015
13
Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid. 61
24777761 2014
14
Central primary primitive neuroectodermal tumor (cPNET) arising from an ovarian mature cystic teratoma in pregnancy: A case report and review of medical literature. 61
24371678 2013
15
Extending the phenotypes associated with DICER1 mutations. 61
21882293 2011
16
Primary peripheral PNET/Ewing's sarcoma arising in the meninges, confirmed by the presence of the rare translocation t(21;22) (q22;q12). 61
21284749 2011
17
The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors. 61
21267687 2011
18
KIT expression and methylation in medulloblastoma and PNET cell lines and tumors. 61
20853134 2011
19
CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells. 61
20480407 2010
20
Primary Ewing sarcoma of the brain: a case report and literature review. 61
17525681 2007
21
Temozolomide in resistant or relapsed pediatric solid tumors. 61
16047361 2006
22
Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET : case report of a primary spinal PNET occurrence with a critical literature review. 61
16292490 2006
23
[A case of peripheral-type primitive neuroectodermal tumor arising in the dura mater at the frontal base]. 61
15112448 2004
24
Features of proliferation and in vitro drug resistance in central primitive neuro-ectodermal tumours. 61
12060344 2002
25
Alternative EWS-FLI1 fusion gene and MIC2 expression in peripheral and central primitive neuroectodermal tumors. 61
11304041 2001
26
High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy. 61
10231868 1999
27
Vasoactive intestinal peptide (VIP) and VIP receptors: gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood. 61
10188714 1999

Variations for Central Nervous System Primitive Neuroectodermal Neoplasm

Expression for Central Nervous System Primitive Neuroectodermal Neoplasm

Search GEO for disease gene expression data for Central Nervous System Primitive Neuroectodermal Neoplasm.

Pathways for Central Nervous System Primitive Neuroectodermal Neoplasm

Pathways related to Central Nervous System Primitive Neuroectodermal Neoplasm according to GeneCards Suite gene sharing:

(showing 3, show less)
# Super pathways Score Top Affiliating Genes
1 11.79 SYP MYCN GFAP ENO2
2 11.46 SHH NES LIN28A
3 10.82 SYP SHH NES GFAP

GO Terms for Central Nervous System Primitive Neuroectodermal Neoplasm

Biological processes related to Central Nervous System Primitive Neuroectodermal Neoplasm according to GeneCards Suite gene sharing:

(showing 6, show less)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of gene expression GO:0010629 9.56 TP53 SHH MYCN DICER1
2 intermediate filament organization GO:0045109 9.37 SHH GFAP
3 miRNA metabolic process GO:0010586 9.32 LIN28A DICER1
4 pre-miRNA processing GO:0031054 9.16 LIN28A DICER1
5 Bergmann glial cell differentiation GO:0060020 8.96 SHH GFAP
6 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800 8.8 TP53 MYCN LIN28A

Sources for Central Nervous System Primitive Neuroectodermal Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....